OMOTOLA TSARUMI: Open Payments
NPI 1710369376 · VAN NUYS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$584 in 9 payments from 5 companies in 2025. Trend: 2023 $4,222 · 2024 $327 · 2025 $584
Food & beverage: $486Education: $98
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $187 |
| REVANCE THERAPEUTICS, INC. | 2 | $182 |
| Teva Pharmaceuticals USA, Inc. | 1 | $98 |
| MERZ NORTH AMERICA, INC. | 2 | $93 |
| Galderma Laboratories, L.P. | 1 | $24 |
Products named: SPRAVATO, DAXXIFY, Xeomin.
Industry payments across CA — which companies pay providers there.
